Filter
8020
Filtered Results: 8020
Text search:
Human
Recources
for
Health
Featured
Recommendations
710
New Publications
2154
Language
Document type
No document type
4630
Studies & Reports
1364
Guidelines
911
Manuals
425
Strategic & Response Plan
339
Fact sheets
121
Training Material
117
Situation Updates
67
Resource Platforms
14
Infographics
13
Brochures
11
Online Courses
7
App
1
Countries / Regions
Global
352
India
296
Kenya
250
Sierra Leone
175
South Africa
168
Ethiopia
167
Uganda
161
Liberia
157
Nepal
157
Nigeria
153
Western and Central Europe
142
Myanmar / Burma
132
Syria
119
Rwanda
118
Zambia
116
Africa
116
Malawi
115
Latin America and the Carribbean
112
Bangladesh
109
Tanzania
101
Ghana
92
Ukraine
81
Namibia
74
Congo, Democratic Republic of
67
Philippines
65
Lesotho
59
South Sudan
58
South–East Asia Region
52
Guinea
51
Mozambique
51
Eastern Europe
50
Cambodia
49
Zimbabwe
48
Indonesia
48
Asia
48
East and Southern Africa
44
West and Central Africa
44
Haiti
42
Senegal
39
Middle East and North Africa
39
Yemen
38
Botswana
36
Venezuela
32
Burkina Faso
29
Eastern Europe and Central Asia
28
Russia
28
Cameroon
27
Pakistan
26
Afghanistan
25
Germany
23
Eswatini/ Swaziland
23
Brazil
22
Central African Republic
21
Western Pacific Region
20
Jordan
19
Sudan
19
Vietnam
19
Mali
18
Lebanon
18
Colombia
18
Thailand
17
USA
16
Somalia
16
Iraq
15
China
15
Benin
14
Laos
13
Moldova
13
Turkey
12
Madagascar
12
Côte d’Ivoire / Ivory Coast
11
Albania
11
Tajikistan
11
Peru
10
Sri Lanka
9
Palestine
9
Georgia
9
Papua New Guinea
8
Angola
8
Chile
7
Southern Africa
7
Iran
7
North America
7
Niger
6
Chad
6
North Macedonia
6
Bolivia
6
Libya
6
Paraguay
6
Poland
6
Jamaica
6
Guinea-Bissau
5
Gambia
5
Hungary
5
Ecuador
5
Romania
5
Argentina
4
Burundi
4
Mexico
4
Bhutan
4
Canada
4
Timor Leste/ East Timor
4
Japan
4
Saudi Arabia
3
Togo
3
Egypt
3
Malaysia
3
Singapore
3
Croatia
3
Greece
3
Fiji
3
Italy
3
Armenia
3
Kyrgyzstan
3
Australia
3
Turkmenistan
3
Mauritius
3
Tunisia
3
United Kingdom
3
Portugal
3
Spain
3
Belarus
3
Morocco
2
Honduras
2
El Salvador
2
Guatemala
2
Qatar
2
Bulgaria
2
Estonia
2
Lithuania
2
Slovakia
2
Kazakhstan
2
Azerbaijan
2
Mauritania
1
Ireland
1
Vanuatu
1
Serbia
1
Other region
1
Djibouti
1
Uzbekistan
1
Belgium
1
France
1
Maldives
1
Norway
1
South Korea
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
2906
Clinical Guidelines
508
Key Resources
445
Public Health
444
Women & Child Health
419
Capacity Building
154
Pharmacy & Technologies
57
Annual Report MEDBOX
3
General Guidelines
1
Protection & Security
1
Toolboxes
COVID-19
625
Mental Health
620
HIV
605
Disability
390
Planetary Health
384
TB
339
Conflict
267
Rapid Response
249
Caregiver
231
Ebola
230
AMR
224
Global Health Education
176
Refugee
160
NTDs
142
Natural Hazards
135
Pharmacy
120
NCDs
113
Health Financing Toolbox
93
Specific Hazards
54
Social Ethics
47
Cholera
43
Polio
37
Zika
37
Typhoon
6
South Sudan
2
Health Financing
2
Education material for teachers of midwifery
Midwifery education modules - second edition
This WHO Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions across the female life cour...
Manual for Early Implementation
This handbook is for health care providers involved in the care of girls and women who have been subjected to any form of female genital mutilation (FGM). This includes obstetricians and gynaecologi...
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was developed initially using the standardized operating proce...
Document on key points needed to design, manage, deliver and evaluate training
You can also find a spanish and french version here: http://reprolineplus.org/resources/training-works-what-you-need-know-about-managing-designing-delivering-and-evalu...
Female genital schistosomiasis:
recommended
A pocket atlas for clinical health-care professionals
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Assessing and improving quality and human rights in mental health and social care facilites
In response to the first cases of coronavirus disease 2019 (COVID-19) reported on the continent, many African Union Member States implemented large-scale public health and social measures (PHSM) rapidly. These measures were aimed at reducing transmi...
Climate change has important implications for the health and futures of children and young people, yet they have little power to limit its harm, making them vulnerable to climate anxiety. This is th...
The microbiology laboratory database software.
WHONET is a desktop Windows application for the management and analysis of microbiology laboratory data with a particular focus on antimicrobial resistance surveillance. WHONET, available in 28 languag...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates ... hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/
This Framework offers a coherent approach for eliminating tuberculosis (TB) in low-incidence countries. It is designed to guide national policy-makers and those responsible for technical aspects of ...
District Level M & E Training and Reference Material for Primary Health Care Programmes
Blueprint for EECA countries, first edition
